Unconjugated Primary Antibodies

Sort by

Collection Menu

Lane 1: Human A431 cell lysates; Lane 2: Human A549 cell lysates probed with RBM47 Polyclonal Antibody, Unconjugated (bs-19774R) at 1:1000 dilution and 4\u00b0C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37˚C. — RBM47 Polyclonal Antibody

Catalog #1: bs-19774R

Applications: WB, ELISA, IHC-P, IHC-F, IF(ICC), IF

Reactivity: Human, Rat

Conjugate: Unconjugated

Neural retinal specific leucine zipper/NRL Polyclonal Antibody

Catalog #1: bs-19351R

Applications: WB, ELISA, IHC-P, IHC-F, IF(ICC), IF

Reactivity: Human, Rat

Conjugate: Unconjugated

Western blot analysis of extracts from normal (control) and ATOX1 knockout (KO) 293T cells, using ATOX1 antibody (bs-34235R) at 1:1000 dilution.\r\n Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) at 1:10000 dilution.\r\n Lysates\/proteins: 25ug per lane.\r\n Blocking buffer: 3% nonfat dry milk in TBST. — ATOX1 Polyclonal Antibody

Catalog #1: bs-34235r

Applications: WB, ICC/IF

Reactivity: Human

Conjugate: Unconjugated

25 ug total protein per lane of various lysates (see on figure) probed with HDAC6 monoclonal antibody, unconjugated (bsm-52086R) at 1:5000 dilution and 4\u00b0C overnight incubation. Followed by conjugated secondary antibody incubation at r.t. for 60 min. — HDAC6 Recombinant Antibody

Catalog #1: bsm-52086r

Applications: WB, IHC-P, IHC-F, IF, ICC/IF

Reactivity: Human

Conjugate: Unconjugated

Paraformaldehyde-fixed, paraffin embedded Human Testicles; Antigen retrieval by boiling in sodium citrate buffer (pH6.0) for 15 min; Antibody incubation with HDAC6 Monoclonal Antibody, Unconjugated(bsm-52086R) at 1:200 overnight at 4\u00b0C, followed by conjugation to the bs-0295G-HRP and DAB (C-0010) staining. — HDAC6 Recombinant Antibody

Catalog #1: bsm-52086r

Applications: WB, IHC-P, IHC-F, IF, ICC/IF

Reactivity: Human

Conjugate: Unconjugated

25 ug total protein per lane of various lysates (see on figure) probed with NOX2 monoclonal antibody, unconjugated (bsm-52603R) at 1:2000 dilution and 4\u00b0C overnight incubation. Followed by conjugated secondary antibody incubation at r.t. for 60 min. — NOX2 Recombinant Antibody

Catalog #1: bsm-52603r-100ul

Applications: WB

Reactivity: Human, Mouse, Rat

Conjugate: Unconjugated

Paraformaldehyde-fixed, paraffin embedded Mouse Pancreas; Antigen retrieval by boiling in sodium citrate buffer (pH6.0) for 15 min; The section was incubated with PRNP Monoclonal Antibody, Unconjugated (bsm-52505R) at 1:200 overnight at 4\u00b0C, followed by conjugation to the bs-0295G-HRP and DAB (C-0010) staining. — PRNP Recombinant Antibody

Catalog #1: bsm-52505r-100ul

Applications: WB, FCM, IHC-P, IHC-F, IF(IHC-P), IF(ICC)

Reactivity: Human, Mouse, Rat

Conjugate: Unconjugated

Paraformaldehyde-fixed, paraffin embedded Rat Pancreas; Antigen retrieval by boiling in sodium citrate buffer (pH6.0) for 15 min; The section was incubated with PRNP Monoclonal Antibody, Unconjugated (bsm-52505R) at 1:200 overnight at 4\u00b0C, followed by conjugation to the bs-0295G-HRP and DAB (C-0010) staining. — PRNP Recombinant Antibody

Catalog #1: bsm-52505r-100ul

Applications: WB, FCM, IHC-P, IHC-F, IF(IHC-P), IF(ICC)

Reactivity: Human, Mouse, Rat

Conjugate: Unconjugated

The Hela ( treated with 200J\/m2 UV-C then recovery for 30 min) (H) cells were fixed with 4% PFA (10 min at r.t.) and then permeabilized with 90% ice-cold methanol for 20 min at -20\u2103,the cells then were incubated in 5%BSA to block non-specific protein-protein interactions (30 min at r.t.), followed by secondary antibody incubation for 40 min at room temperature.Primary Antibody (green):Rabbit Anti-p-Hsp27 (S78) antibody (bsm-52167R,1:100); Isotype Control (orange): Rabbit IgG (bs-0295P). Blank control (black): PBS. Acquisition of 20,000 events was performed. — Phospho-HSP27 (Ser78) Recombinant Antibody

Catalog #1: bsm-52167r

Applications: WB, ELISA, IHC-P, IHC-F, IF, Flow-Cyt, ICC/IF

Reactivity: Human

Conjugate: Unconjugated

Hela (H) cells were treated with or without UV (40 mJ\/cm2) for 30 min and anisomycin (25 \u03bcg\/mL) for 30 min , 25 \u03bcg total protein per lane of cell lysates (see on figure) probed with Phospho-HSP27 (Ser78) monoclonal antibody, unconjugated (bsm-52167R) at 1:1000 dilution and 4\u00b0C overnight incubation. Followed by conjugated secondary antibody incubation at r.t. for 60 min. — Phospho-HSP27 (Ser78) Recombinant Antibody

Catalog #1: bsm-52167r

Applications: WB, ELISA, IHC-P, IHC-F, IF, Flow-Cyt, ICC/IF

Reactivity: Human

Conjugate: Unconjugated

phospho-Smad2 (Ser255) Recombinant Antibody

Catalog #1: bsm-52204r

Applications: WB, IHC-P, IHC-F, IF, ICC/IF

Reactivity: Human, Mouse

Conjugate: Unconjugated

25 ug total protein per lane of various lysates (see on figure) probed with C-jun monoclonal antibody, unconjugated (bsm-52035R) at 1:1000 dilution and 4\u00b0C overnight incubation. Followed by conjugated secondary antibody incubation at r.t. for 60 min. — c-Jun Recombinant Antibody

Catalog #1: bsm-52035r

Applications: WB

Reactivity: Human, Mouse

Conjugate: Unconjugated

Lane 1: Jurkat; Lane 2: K562; Lane 3: Hela lysates probed with Cdk6 (4F7) Monoclonal Antibody (bsm-52030R) at 1:1000 overnight at 4˚C. Followed by a conjugated secondary antibody . — Cdk6 Recombinant Antibody

Catalog #1: bsm-52030r

Applications: WB, Flow-Cyt, ICC/IF

Reactivity: Human

Conjugate: Unconjugated

SW480 cells were stained with Cdk6 (4F7) Monoclonal Antibody (bsm-52030R) at [1:200] incubated overnight at 4C, followed by secondary antibody incubation, DAPI staining of the nuclei and detection. — Cdk6 Recombinant Antibody

Catalog #1: bsm-52030r

Applications: WB, Flow-Cyt, ICC/IF

Reactivity: Human

Conjugate: Unconjugated

25 ug total protein per lane of various lysates (see on figure) probed with 14-3-3 Tau monoclonal antibody, unconjugated (bsm-52006R) at 1:1000 dilution and 4\u00b0C overnight incubation. Followed by conjugated secondary antibody incubation at r.t. for 60 min. — 14-3-3 Tau Recombinant Antibody

Catalog #1: bsm-52006r

Applications: WB, Flow-Cyt, ICC/IF

Reactivity: Human, Mouse, Rat

Conjugate: Unconjugated

25 ug total protein per lane of various lysates (see on figure) probed with STAT5b monoclonal antibody, unconjugated (bsm-52238R) at 1:1000 dilution and 4\u00b0C overnight incubation. Followed by conjugated secondary antibody incubation at r.t. for 60 min. — STAT5b Recombinant Antibody

Catalog #1: bsm-52238r

Applications: WB, IHC-P, IHC-F, IF

Reactivity: Human, Mouse, Rat

Conjugate: Unconjugated

Paraformaldehyde-fixed, paraffin embedded Mouse Liver; Antigen retrieval by boiling in sodium citrate buffer (pH6.0) for 15 min; The section was incubated with STAT5b Monoclonal Antibody, Unconjugated (bsm-52238R) at 1:200 overnight at 4\u00b0C, followed by conjugation to the bs-0295G-HRP and DAB (C-0010) staining. — STAT5b Recombinant Antibody

Catalog #1: bsm-52238r

Applications: WB, IHC-P, IHC-F, IF

Reactivity: Human, Mouse, Rat

Conjugate: Unconjugated

Lane 1: Mouse Stomach tissue lysates; Lane 2: Rat Stomach tissue lysates; Lane 3: Human MKN45 cell lysates probed with PGA3 Polyclonal Antibody, Unconjugated (bs-7369R) at 1:1000 dilution and 4\u00b0C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37˚C. — PGA3 Polyclonal Antibody

Catalog #1: bs-7369R

Applications: WB, ELISA, IHC-P, IHC-F, IF, ICC/IF

Reactivity: Human, Mouse, Rat

Conjugate: Unconjugated

Lane 1: rat lung lysates probed with Rabbit Anti-GAD65 Polyclonal Antibody, Unconjugated (bs-0325R) at 1:300 overnight at 4˚C. Followed by conjugation to secondary antibody (bs-0295G-HRP) at 1:5000 for 90 min at 37˚C. — GAD65 Polyclonal Antibody

Catalog #1: bs-0325R

Applications: WB, ELISA

Reactivity: Human, Mouse, Rat

Conjugate: Unconjugated

Lane 1: Mouse Cerebrum tissue lysates; Lane 2: Mouse Cerebellum tissue lysates; Lane 3: Mouse Hippocampus tissue lysates; Lane 4: Rat Cerebrum tissue lysates; Lane 5: Rat Cerebellum tissue lysates; Lane 6: Rat Hippocampus tissue lysates; Lane 7: Human SH-SY5Y cell lysates; Lane 8: Human U-87 MG cell lysates; Lane 9: Human Hela cell lysates; Lane 10: Human Jurkat cell lysates probed with GAD65 Polyclonal Antibody, Unconjugated (bs-0325R) at 1:1000 dilution and 4\u00b0C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37˚C. — GAD65 Polyclonal Antibody

Catalog #1: bs-0325R

Applications: WB, ELISA

Reactivity: Human, Mouse, Rat

Conjugate: Unconjugated

FAM43B Polyclonal Antibody

Catalog #1: bs-14993R

Applications: IHC-P, IHC-F, IF(ICC), IF

Reactivity: Mouse, Rat

Conjugate: Unconjugated

CNG3 Polyclonal Antibody

Catalog #1: bs-10772R

Applications: WB, ELISA, IHC-P, IHC-F, IF(IHC-P), IF(IHC-F), IF(ICC)

Reactivity:

Conjugate: Unconjugated

Lane 1: Recombinant SARS-CoV-2 N protein (WT) (His Tag) (bs-41408P); Lane 2: Recombinant SARS-CoV-2 N protein (Q9H, P67S, P80R, P151L, S183Y) (His Tag) (bs-41451P); Lane 3: Recombinant SARS-CoV-2 N protein (D3L, P13T, D103Y, D128Y, H145Y, R203K, G204R, T205I, S235F) (His Tag) (bs-41452P); Lane 4: Recombinant SARS-CoV-2 N protein (Del204, Del215) (His Tag) (bs-41491P); Lane 5: Recombinant SARS-Cov-2 N protein (R203M, D377Y) (His Tag) (bs-41492P); Lane 6: Recombinant SARS-Cov-2 (Omicron, B.1.1.529) N protein (P13L, E31del, R32del, S33del, R203K, G204R) (N-His Tag) (bs-41494P) probed with SARS-CoV-2 (2019-nCoV) Nucleocapsid Monoclonal Antibody, Unconjugated (bsm-41518M) at 1:1000 dilution and 4\u00b0C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37˚C. — SARS-CoV-2 (2019-nCoV) Nucleocapsid Monoclonal Antibody

Catalog #1: bsm-41518M

Applications: WB

Reactivity: SARS-CoV-2

Conjugate: Unconjugated

Lane 1: Recombinant SARS-CoV-2 N protein (WT) (His Tag) (bs-41408P); Lane 2: Recombinant SARS-CoV-2 N protein (Q9H, P67S, P80R, P151L, S183Y) (His Tag) (bs-41451P; Lane 3: Recombinant SARS-CoV-2 N protein (D3L, P13T, D103Y, D128Y, H145Y, R203K, G204R, T205I, S235F) (His Tag) (bs-41452P); Lane 4: Recombinant SARS-CoV-2 N protein (Del204, Del215) (His Tag) (bs-41491P); Lane 5: Recombinant SARS-Cov-2 N protein (R203M, D377Y) (His Tag) (bs-41492P) probed with SARS-CoV-2 (2019-nCoV) Nucleocapsid Monoclonal Antibody, Unconjugated (bsm-41517M) at 1:1000 dilution and 4\u00b0C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37˚C. — SARS-CoV-2 (2019-nCoV) Nucleocapsid Monoclonal Antibody

Catalog #1: bsm-41517M

Applications: WB

Reactivity: SARS-CoV-2

Conjugate: Unconjugated

Lane 1: Recombinant SARS-CoV-2 N protein (WT) (His Tag) (bs-41408P); Lane 2: Recombinant SARS-CoV-2 N protein (Q9H, P67S, P80R, P151L, S183Y) (His Tag) (bs-41451P); Lane 3: Recombinant SARS-CoV-2 N protein (D3L, P13T, D103Y, D128Y, H145Y, R203K, G204R, T205I, S235F) (His Tag) (bs-41452P); Lane 4: Recombinant SARS-CoV-2 N protein (Del204, Del215) (His Tag) (bs-41491P); Lane 5: Recombinant SARS-Cov-2 N protein (R203M, D377Y) (His Tag) (bs-41492P); Lane 6: Recombinant SARS-Cov-2 (Omicron, B.1.1.529) N protein (P13L, E31del, R32del, S33del, R203K, G204R) (N-His Tag) (bs-41494P) probed with SARS-CoV-2 (2019-nCoV) Nucleocapsid Monoclonal Antibody, Unconjugated (bsm-41504M) at 1:1000 dilution and 4\u00b0C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37˚C. — SARS-CoV-2 (2019-nCoV) Nucleocapsid Monoclonal Antibody

Catalog #1: bsm-41504m

Applications: WB

Reactivity: SARS-CoV-2

Conjugate: Unconjugated

Lane 1: Recombinant SARS-CoV-2 N protein (WT) (His Tag) (bs-41408P); Lane 2: Recombinant SARS-CoV-2 N protein (Q9H, P67S, P80R, P151L, S183Y) (His Tag) (bs-41451P); Lane 3: Recombinant SARS-CoV-2 N protein (D3L, P13T, D103Y, D128Y, H145Y, R203K, G204R, T205I, S235F) (His Tag) (bs-41452P); Lane 4: Recombinant SARS-CoV-2 N protein (Del204, Del215) (His Tag) (bs-41491P); Lane 5: Recombinant SARS-Cov-2 N protein (R203M, D377Y) (His Tag) (bs-41492P); Lane 6: Recombinant SARS-Cov-2 (Omicron, B.1.1.529) N protein (P13L, E31del, R32del, S33del, R203K, G204R) (N-His Tag) (bs-41494P) probed with SARS-CoV-2 (2019-nCoV) Nucleocapsid Monoclonal Antibody, Unconjugated (bsm-41503M) at 1:1000 dilution and 4\u00b0C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37˚C. — SARS-CoV-2 (2019-nCoV) Nucleocapsid Monoclonal Antibody

Catalog #1: bsm-41503m

Applications: WB

Reactivity: SARS-CoV-2

Conjugate: Unconjugated

Lane 1: Human K562 cell lysates; Lane 2: Human Jurkat cell lysates; Lane 3: Human HeLa cell lysates; Lane 4: Human HepG2 cell lysates; Lane 5: Human 293T cell lysates probed with MIST1 Monoclonal Antibody, Unconjugated (bsm-34219M) at 1:1000 dilution and 4\u00b0C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37˚C. — BHLHA15 Monoclonal Antibody

Catalog #1: bsm-34219M

Applications: WB

Reactivity: Human

Conjugate: Unconjugated

Lane 1: Recombinant SARS-CoV-2 N protein (WT) (His Tag) (bs-41408P); Lane 2: Recombinant SARS-CoV-2 N protein (Q9H, P67S, P80R, P151L, S183Y) (His Tag) (bs-41451P); Lane 3: Recombinant SARS-CoV-2 N protein (D3L, P13T, D103Y, D128Y, H145Y, R203K, G204R, T205I, S235F) (His Tag) (bs-41452P); Lane 4: Recombinant SARS-CoV-2 N protein (Del204, Del215) (His Tag) (bs-41491P); Lane 5: Recombinant SARS-Cov-2 N protein (R203M, D377Y) (His Tag) (bs-41492P); Lane 6: Recombinant SARS-Cov-2 (Omicron, B.1.1.529) N protein (P13L, E31del, R32del, S33del, R203K, G204R) (N-His Tag) (bs-41494P) probed with SARS-CoV-2 (2019-nCoV) Nucleocapsid Monoclonal Antibody, Unconjugated (bsm-41513M) at 1:1000 dilution and 4\u00b0C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37˚C. — SARS-CoV-2 (2019-nCoV) Nucleocapsid Monoclonal Antibody

Catalog #1: bsm-41513M

Applications: WB

Reactivity: SARS-CoV-2

Conjugate: Unconjugated

Lane 1: Recombinant SARS-CoV-2 N protein (WT) (His Tag) (bs-41408P); Lane 2: Recombinant SARS-CoV-2 N protein (Q9H, P67S, P80R, P151L, S183Y) (His Tag) (bs-41451P); Lane 3: Recombinant SARS-CoV-2 N protein (D3L, P13T, D103Y, D128Y, H145Y, R203K, G204R, T205I, S235F) (His Tag) (bs-41452P); Lane 4: Recombinant SARS-CoV-2 N protein (Del204, Del215) (His Tag) (bs-41491P); Lane 5: Recombinant SARS-Cov-2 N protein (R203M, D377Y) (His Tag) (bs-41492P); Lane 6: Recombinant SARS-Cov-2 (Omicron, B.1.1.529) N protein (P13L, E31del, R32del, S33del, R203K, G204R) (N-His Tag) (bs-41494P) probed with SARS-CoV-2 (2019-nCoV) Nucleocapsid Monoclonal Antibody, Unconjugated (bsm-41512M) at 1:1000 dilution and 4\u00b0C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37˚C. — SARS-CoV-2 (2019-nCoV) Nucleocapsid Monoclonal Antibody

Catalog #1: bsm-41512M

Applications: WB

Reactivity: SARS-CoV-2

Conjugate: Unconjugated

Lane 1: Recombinant SARS-CoV-2 N protein (WT) (His Tag) (bs-41408P); Lane 2: Recombinant SARS-CoV-2 N protein (Q9H, P67S, P80R, P151L, S183Y) (His Tag) (bs-41451P); Lane 3: Recombinant SARS-CoV-2 N protein (D3L, P13T, D103Y, D128Y, H145Y, R203K, G204R, T205I, S235F) (His Tag) (bs-41452P); Lane 4: Recombinant SARS-CoV-2 N protein (Del204, Del215) (His Tag) (bs-41491P); Lane 5: Recombinant SARS-Cov-2 N protein (R203M, D377Y) (His Tag) (bs-41492P); Lane 6: Recombinant SARS-Cov-2 (Omicron, B.1.1.529) N protein (P13L, E31del, R32del, S33del, R203K, G204R) (N-His Tag) (bs-41494P) probed with SARS-CoV-2(2019-nCoV)Nucleocapsid Monoclonal Antibody, Unconjugated (bsm-41483M) at 1:1000 dilution and 4\u00b0C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37˚C. — SARS-CoV-2 (2019-nCoV) Nucleocapsid Monoclonal Antibody

Catalog #1: bsm-41483M

Applications: WB

Reactivity: SARS-CoV-2

Conjugate: Unconjugated

Lane 1: Recombinant SARS-CoV-2 N protein (WT) (His Tag) (bs-41408P); Lane 2: Recombinant SARS-CoV-2 N protein (Q9H, P67S, P80R, P151L, S183Y) (His Tag) (bs-41451P); Lane 3: Recombinant SARS-CoV-2 N protein (D3L, P13T, D103Y, D128Y, H145Y, R203K, G204R, T205I, S235F) (His Tag) (bs-41452P); Lane 4: Recombinant SARS-CoV-2 N protein (Del204, Del215) (His Tag) (bs-41491P); Lane 5: Recombinant SARS-Cov-2 N protein (R203M, D377Y) (His Tag) (bs-41492P); Lane 6: Recombinant SARS-Cov-2 (Omicron, B.1.1.529) N protein (P13L, E31del, R32del, S33del, R203K, G204R) (N-His Tag) (bs-41494P) probed with SARS-CoV-2(2019-nCoV)Nucleocapsid Monoclonal Antibody, Unconjugated (bsm-41482M) at 1:1000 dilution and 4\u00b0C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37˚C. — SARS-CoV-2 (2019-nCoV) Nucleocapsid Monoclonal Antibody

Catalog #1: bsm-41482M

Applications: WB

Reactivity: SARS-CoV-2

Conjugate: Unconjugated

Lane 1: Recombinant human VEGFR1 protein, C-His (HEK293) probed with sFlt1 Monoclonal Antibody, Unconjugated (bsm-41611M) at 1:1000 dilution and 4\u00b0C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37˚C. — sFlt1 Monoclonal Antibody

Catalog #1: bsm-41611m-100ul

Applications: WB

Reactivity: Human

Conjugate: Unconjugated

Lane 1: Recombinant human ST2 protein, His (HEK293) lysates probed with Interleukin-1 receptor-like 1\/ST2 Monoclonal Antibody, Unconjugated (bsm-43005M) at 1:1000 dilution and 4\u00b0C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37˚C. — Interleukin-1 receptor-like 1/ST2 Monoclonal Antibody

Catalog #1: bsm-43005M

Applications: WB

Reactivity: Human

Conjugate: Unconjugated

Lane 1: Recombinant human Beta-2-microglobulin, C-His (HEK293) probed with beta 2 Microglobulin Monoclonal Antibody, Unconjugated (bsm-43094M) at 1:1000 dilution and 4\u00b0C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37˚C. — beta 2 Microglobulin Monoclonal Antibody

Catalog #1: bsm-43094m-100ul

Applications: WB

Reactivity: Human

Conjugate: Unconjugated

Lane 1: Human HeLa cell lysates; Lane 2: Human Jurkat cell lysates; Lane 3: Human HepG2 cell lysates; Lane 4: Human Raji cell lysates; Lane 5: Human PANC-1 cell lysates probed with beta 2 Microglobulin Monoclonal Antibody, Unconjugated (bsm-43094M) at 1:1000 dilution and 4\u00b0C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37˚C. — beta 2 Microglobulin Monoclonal Antibody

Catalog #1: bsm-43094m-100ul

Applications: WB

Reactivity: Human

Conjugate: Unconjugated

Lane 1: Recombinant human Alpha 1 Microglobulin (HEK293)( bs-43007P) probed with Alpha 1 microglobulin Monoclonal Antibody, Unconjugated (bsm-43007M) at 1:1000 dilution and 4\u00b0C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37˚C. — Alpha 1 microglobulin Monoclonal Antibody

Catalog #1: bsm-43007M

Applications: WB

Reactivity: Human

Conjugate: Unconjugated

25 ug total protein per lane of various lysates (see on figure) probed with PRL monoclonal antibody, unconjugated (bsm-43099M) at 1:1000 dilution and 4\u00b0C overnight incubation. Followed by conjugated secondary antibody incubation at r.t. for 60 min. — PRL Monoclonal Antibody

Catalog #1: bsm-43099m-100ul

Applications: IHC-P, IHC-F, IF(IHC-P)

Reactivity: Human

Conjugate: Unconjugated

Paraformaldehyde-fixed, paraffin embedded Human pituitary; Antigen retrieval by boiling in sodium citrate buffer (pH6.0) for 15 min; The section was incubated with PRL Monoclonal Antibody, Unconjugated (bsm-43099M) at 1:200 overnight at 4\u00b0C, followed by conjugation to the bs-40296G-HRP and DAB (C-0010) staining. — PRL Monoclonal Antibody

Catalog #1: bsm-43099m-100ul

Applications: IHC-P, IHC-F, IF(IHC-P)

Reactivity: Human

Conjugate: Unconjugated

THP-1 (H) cells were treated with or without TPA (80 nM) and LPS (100 ng\/ml\uff0c6h) and Brefeldin A (300 ng\/ml\uff0c3h) , 25 \u03bcg total protein per lane of cell lysates (see on figure) probed with IL-6 monoclonal antibody, unconjugated (bsm-43079M) at 1:1000 dilution and 4\u00b0C overnight incubation. Followed by conjugated secondary antibody incubation at r.t. for 60 min. — IL-6 Monoclonal Antibody

Catalog #1: bsm-43079m-100ul

Applications: WB

Reactivity: Human

Conjugate: Unconjugated

Lane 1: Mouse Lymph node tissue lysates; Lane 2: Mouse Thymus tissue lysates; Lane 3: Mouse Bone tissue lysates probed with TRIM30 Polyclonal Antibody, Unconjugated (bs-16732R) at 1:1000 dilution and 4\u00b0C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37˚C. — TRIM30 Polyclonal Antibody

Catalog #1: bs-16732R

Applications: WB

Reactivity: Mouse

Conjugate: Unconjugated

Lane 1: Human HepG2 cell lysates; Lane 2: Human HeLa cell lysates probed with TMPRSS2 Polyclonal Antibody, Unconjugated (bs-41361R) at 1:1000 dilution and 4\u00b0C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37˚C. — TMPRSS2 Polyclonal Antibody

Catalog #1: bs-41361r

Applications: WB, ELISA

Reactivity: Human

Conjugate: Unconjugated

Lane 1: Mouse Lung tissue lysates; Lane 2: Human HL-60 cell lysates probed with CD80 Polyclonal Antibody, Unconjugated (bs-41304R) at 1:500 dilution and 4\u00b0C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37˚C. — CD80 Polyclonal Antibody

Catalog #1: bs-41304r

Applications: WB, ELISA

Reactivity: Human, Mouse

Conjugate: Unconjugated

Lane 1: Mouse Testis tissue lysates; Lane 2: Rat Testis tissue lysates; Lane 3: Human HeLa cell lysates; Lane 4: Human Raji cell lysates; Lane 5: Human HepG2 cell lysates probed with Phospho-SREBP2(Thr334) Polyclonal Antibody, Unconjugated (bs-24293R) at 1:1000 dilution and 4\u00b0C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37˚C. — Phospho-SREBP2 (Thr334) Polyclonal Antibody

Catalog #1: bs-24293R

Applications: WB

Reactivity: Human, Mouse, Rat

Conjugate: Unconjugated

Lane 1: Mouse Testis tissue lysates; Lane 2: Rat Testis tissue lysates; Lane 3: Human HeLa cell lysates; Lane 4: Human Raji cell lysates; Lane 5: Human HepG2 cell lysates probed with Phospho-SREBP2(Thr334) Polyclonal Antibody, Unconjugated (bs-24294R) at 1:1000 dilution and 4\u00b0C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37˚C. — Phospho-SREBP2 (Thr334) Polyclonal Antibody

Catalog #1: bs-24294R

Applications: WB

Reactivity: Human, Mouse, Rat

Conjugate: Unconjugated

Lane 1: Human Hela cell lysates; Lane 2: Human HepG2 cell lysates probed with SLCO2B1 Polyclonal Antibody, Unconjugated (bs-25183R) at 1:1000 dilution and 4\u00b0C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37˚C. — WNT7A Polyclonal Antibody

Catalog #1: bs-25183R

Applications: WB

Reactivity: Human

Conjugate: Unconjugated

Lane 1: Mouse Cerebrum tissue lysates; Lane 2: Mouse Cerebellum tissue lysates; Lane 3: Rat Cerebrum tissue lysates; Lane 4: Rat Cerebellum tissue lysates probed with Neurotrophin 3 Polyclonal Antibody, Unconjugated (bs-41378R) at 1:1000 dilution and 4\u00b0C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37˚C. — Neurotrophin 3 Polyclonal Antibody

Catalog #1: bs-41378r

Applications: WB, ELISA

Reactivity: Mouse, Rat

Conjugate: Unconjugated

Lane 1: Mouse Cerebrum tissue lysates; Lane 2: Mouse Cerebellum tissue lysates; Lane 3: Rat Cerebrum tissue lysates probed with alpha Internexin Polyclonal Antibody, Unconjugated (bs-42003R) at 1:1000 dilution and 4\u00b0C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37˚C. — alpha Internexin Polyclonal Antibody

Catalog #1: bs-42003r

Applications: WB, ELISA

Reactivity: Human, Mouse, Rat

Conjugate: Unconjugated

Lane 1: Human SH-SY5Y cell lysates; Lane 2: Human SH-SY5Y cell lysates probed with alpha Internexin Polyclonal Antibody, Unconjugated (bs-42003R) at 1:1000 dilution and 4\u00b0C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37˚C. — alpha Internexin Polyclonal Antibody

Catalog #1: bs-42003r

Applications: WB, ELISA

Reactivity: Human, Mouse, Rat

Conjugate: Unconjugated

Lane 1: Human Hela cell lysates probed with AMH Polyclonal Antibody, Unconjugated (bs-43520R) at 1:1000 dilution and 4\u00b0C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37˚C. — AMH Polyclonal Antibody

Catalog #1: bs-43520R

Applications: WB

Reactivity: Human

Conjugate: Unconjugated

Lane 1: Human K562 cell lysates; Lane 2: Human A431 cell lysates probed with MSH2 Polyclonal Antibody, Unconjugated (bs-23630R) at 1:1000 dilution and 4\u00b0C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37˚C. — MSH2 Polyclonal Antibody

Catalog #1: bs-23630R

Applications: WB

Reactivity: Human

Conjugate: Unconjugated

Lane 1: Mouse Raw264.7 cell(lps) lysates; Lane 2: Human THP-1 cell(lps) lysates; Lane 3: Human A549 cell lysates probed with Cyclooxygenase 2 Polyclonal Antibody, Unconjugated (bs-41439R) at 1:1000 dilution and 4\u00b0C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37˚C. — Cyclooxygenase 2 Polyclonal Antibody

Catalog #1: bs-41439R

Applications: WB

Reactivity: Human, Mouse

Conjugate: Unconjugated

Lane 1: Mouse Liver tissue lysates; Lane 2: Rat Liver tissue lysates probed with CEBP Beta Polyclonal Antibody, Unconjugated (bs-25032R) at 1:1000 dilution and 4\u00b0C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37˚C. — CEBP Beta Polyclonal Antibody

Catalog #1: bs-25032R

Applications: WB

Reactivity: Mouse, Rat

Conjugate: Unconjugated

Lane 1: Human HL-60 cell lysates; Lane 2: Human K562 cell lysates; Lane 3: Human A549 cell lysates probed with DDX3 Polyclonal Antibody, Unconjugated (bs-25034R) at 1:1000 dilution and 4\u00b0C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37˚C. — DDX3 Polyclonal Antibody

Catalog #1: bs-25034R

Applications: WB

Reactivity: Human

Conjugate: Unconjugated

Lane 1: Human HepG2 cell lysates; Lane 2: Human Jurkat cell lysates probed with CD7 Polyclonal Antibody, Unconjugated (bs-10674R) at 1:1000 dilution and 4\u00b0C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37˚C. — CD7 Polyclonal Antibody

Catalog #1: bs-10674R

Applications: WB

Reactivity: Human, Mouse

Conjugate: Unconjugated

Lane 1: Human Jurkat cell lysates; Lane 2: Human Huvec cell lysates; Lane 3: Human Molt-4 cell lysates; Lane 4: Human Hepg2 cell lysates; Lane 5: Human K562 cell lysates probed with Caspase-10 Polyclonal Antibody, Unconjugated (bs-23454R) at 1:1000 dilution and 4\u00b0C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37˚C. — Caspase-10 Polyclonal Antibody

Catalog #1: bs-23454r

Applications: WB, IHC-P, IHC-F, IF

Reactivity: Human

Conjugate: Unconjugated

Lane 1: Mouse Cerebrum tissue lysates; Lane 2: Mouse Kidney tissue lysates; Lane 3: Mouse Pancreas tissue lysates; Lane 4: Rat Cerebrum tissue lysates; Lane 5: Rat Cerebellum tissue lysates; Lane 6: Rat Kidney tissue lysates; Lane 7: Human A431 cell lysates; Lane 8: Human SH-SY5Y cell lysates probed with LPA1 Polyclonal Antibody, Unconjugated (bs-22138R) at 1:1000 dilution and 4\u00b0C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37˚C. — LPA1 Polyclonal Antibody

Catalog #1: bs-22138R

Applications: WB

Reactivity: Human, Mouse, Rat

Conjugate: Unconjugated

FLVCR2 Polyclonal Antibody

Catalog #1: bs-16147R

Applications: WB, ELISA, IHC-P, IHC-F, IF

Reactivity: Mouse

Conjugate: Unconjugated